bioAffinity Technologies, Inc.
No trades
Fundamentals and stats
Top segments and regional performance
Last year, the company generated 9.36 M USD, the most of which — 9.35 M USD — came from its top-performing segment, Laboratory Services, compared to 2.51 M USD the previous year. The greatest contribution came from United States, which accounted for 9.36 M USD last year, with 2.53 M USD the year before.
By source
By country